$692 Million is the total value of BBR PARTNERS, LLC's 110 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 50.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HUM | Sell | HUMANA INC | $29,392,000 | +13.7% | 86,826 | -0.0% | 4.25% | -2.3% |
XOM | Sell | EXXON MOBIL CORP | $11,514,000 | -10.5% | 135,428 | -12.9% | 1.66% | -23.1% |
KO | Sell | COCA COLA CO | $4,698,000 | -18.7% | 101,718 | -22.8% | 0.68% | -30.1% |
SCHW | Sell | SCHWAB CHARLES CORP NEW | $737,000 | -3.9% | 14,952 | -0.3% | 0.11% | -17.1% |
IWB | Sell | ISHARES TRrus 1000 etf | $596,000 | -22.9% | 3,685 | -27.5% | 0.09% | -33.8% |
DSI | Sell | ISHARES TRmsci kld400 soc | $408,000 | +3.8% | 3,823 | -1.8% | 0.06% | -10.6% |
VZ | Sell | VERIZON COMMUNICATIONS INC | $392,000 | -0.8% | 7,340 | -6.5% | 0.06% | -13.6% |
HEDJ | Sell | WISDOMTREE TReurope hedged eq | $345,000 | -76.2% | 5,460 | -76.2% | 0.05% | -79.5% |
PH | Sell | PARKER HANNIFIN CORP | $336,000 | +4.0% | 1,827 | -11.9% | 0.05% | -9.3% |
CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $222,000 | -52.8% | 5,000 | -37.5% | 0.03% | -59.5% |
NYCB | Exit | NEW YORK CMNTY BANCORP INC | $0 | – | -12,001 | -100.0% | -0.02% | – |
OMED | Exit | ONCOMED PHARMACEUTICALS INC | $0 | – | -61,649 | -100.0% | -0.02% | – |
MLPI | Exit | UBS AG JERSEY BRHalerian infrst | $0 | – | -9,404 | -100.0% | -0.04% | – |
AMLP | Exit | ALPS ETF TRalerian mlp | $0 | – | -22,750 | -100.0% | -0.04% | – |
IWF | Exit | ISHARES TRrus 1000 grw etf | $0 | – | -1,750 | -100.0% | -0.04% | – |
ECON | Exit | COLUMBIA ETF TR IIemrg markets etf | $0 | – | -10,910 | -100.0% | -0.04% | – |
UBS | Exit | UBS GROUP AG | $0 | – | -24,745 | -100.0% | -0.06% | – |
KKR | Exit | KKR & CO L P DEL | $0 | – | -20,000 | -100.0% | -0.08% | – |
DXJ | Exit | WISDOMTREE TRjapn hedge eqt | $0 | – | -24,587 | -100.0% | -0.22% | – |
GG | Exit | GOLDCORP INC NEW | $0 | – | -150,000 | -100.0% | -0.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPDR S&P 500 ETF TR | 42 | Q3 2023 | 47.2% |
EXXON MOBIL CORP | 42 | Q3 2023 | 2.2% |
Berkshire Hathaway Inc Del Cl A | 42 | Q3 2023 | 0.8% |
PEPSICO INC | 42 | Q3 2023 | 0.3% |
JOHNSON & JOHNSON | 42 | Q3 2023 | 0.4% |
SPDR GOLD TRUST | 42 | Q3 2023 | 0.5% |
FACEBOOK INC | 42 | Q3 2023 | 0.7% |
APPLE INC | 41 | Q3 2023 | 4.8% |
ARES CAP CORP COM | 41 | Q3 2023 | 0.4% |
GOLDMAN SACHS GROUP INC | 40 | Q3 2023 | 3.9% |
View BBR PARTNERS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Ellington Financial Inc.Sold out | January 28, 2020 | 0 | 0.0% |
View BBR PARTNERS, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-11 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-08 |
View BBR PARTNERS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.